Active Biotech AB (publ) in accordance with a decision made by the Annual General Meeting held on May 24, 2023, the Nomination Committee shall comprise the representatives for the three largest shareholders by votes, as per end of September 2023, and the Chairman of the Board. The company appointed Mats Arnhög and Petter Wingstrand to Nomination Committee. The Nomination Committee is composed with participants representing the largest shareholders in Active Biotech as of September 30, 2023, and consists of: Michael Shalmi, chairman; Mats Arnhög, MGA Holding; Peter Thelin, Sjuenda Holding; Petter Wingstrand, T-bolaget.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.567 SEK | +6.38% | +2.53% | +24.21% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.21% | 18.71M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ACTI Stock
- News Active Biotech AB
- Active Biotech AB Appoints Mats Arnhög and Petter Wingstrand to Nomination Committee